American Portfolios Advisors’s Medifast MED Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
$32.2K Hold
297
﹤0.01% 1951
2022
Q2
$53.6K Hold
297
﹤0.01% 1722
2022
Q1
$50.7K Sell
297
-397
-57% -$74.8K ﹤0.01% 1876
2021
Q4
$145K Buy
694
+397
+134% +$82.1K ﹤0.01% 1315
2021
Q3
$57.2K Hold
297
﹤0.01% 1701
2021
Q2
$84K Sell
297
-20
-6% -$5.42K ﹤0.01% 1481
2021
Q1
$67.1K Buy
317
+70
+28% +$16.8K ﹤0.01% 1477
2020
Q4
$48.5K Buy
247
+50
+25% +$8.84K ﹤0.01% 1422
2020
Q3
$32.4K Buy
197
+40
+25% +$6.59K ﹤0.01% 1491
2020
Q2
$21.8K Buy
+157
New +$14.4K ﹤0.01% 1609
2019
Q4
Sell
-50
Closed -$5.22K 2893
2019
Q3
$5.22K Sell
50
-65
-57% -$6.99K ﹤0.01% 2179
2019
Q2
$14.8K Buy
+115
New +$16K ﹤0.01% 1775

Other funds holding MED

American Portfolios Advisors's MED Position: Q3 2022 in Review

American Portfolios Advisors held its Medifast (MED) position steady in Q3 2022 at 297 shares worth $32.2K. The position accounts for ﹤0.01% of the portfolio, ranked #1951.

American Portfolios Advisors first reported a position in MED in Q2 2019 and has held it in 12 quarters since. The position peaked at $145K in Q4 2021. 264 funds tracked by Wall St. Rank hold MED as of Q3 2022.

  • American Portfolios Advisors held 297 shares of Medifast worth $32.2K as of Q3 2022.
  • American Portfolios Advisors left its Medifast share count unchanged in Q3 2022.
  • Medifast made up ﹤0.01% of American Portfolios Advisors's portfolio in Q3 2022, its #1951 holding.
  • American Portfolios Advisors first reported a position in Medifast in Q2 2019 and has held it in 12 quarters since.
  • American Portfolios Advisors's Medifast position peaked at $145K in Q4 2021.
  • 264 funds tracked by Wall St. Rank held Medifast as of Q3 2022.

Based on American Portfolios Advisors's 13F filing for Q3 2022, filed 17 Mar 2023.